Lilly Venture Revenue and Competitors
Estimated Revenue & Valuation
- Lilly Venture's estimated annual revenue is currently $53.7M per year.
- Lilly Venture's estimated revenue per employee is $201,000
Employee Data
- Lilly Venture has 267 Employees.
- Lilly Venture grew their employee count by -34% last year.
Lilly Venture Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Lilly Venture?
i3 is a global pharmaceutical services company that provides integrated strategies and solutions throughout the product lifecycle.\r\n\r\ni3 Advantage: Your i3 projects and staffing solutions will benefit from the many resources uniquely available to i3 through our corporate ties. i3 is a business unit of Ingenix, a wholly-owned subsidiary of UnitedHealth Group. Ingenix provides knowledge and information services—Intelligence for Health Care™—to UnitedHealth Group businesses.
keywords:N/A
N/A
Total Funding
267
Number of Employees
$53.7M
Revenue (est)
-34%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lilly Venture News
"He brings a wealth of valuable experience and unique perspectives to our Board, having led successful global healthcare ventures focused on...
But the report also notes that even some venture capitalists will concede ... Lilly Asia Ventures, Boyu Capital, Qiming Venture Partners,...
Investors: Temasek, Invesco Developing Markets Fund, Loyal Valley Capital, GL Ventures, Yunfeng Capital, Lilly Asia Ventures, Boyu Capital,...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $89.6M | 267 | 12% | N/A |
#2 | $64.6M | 267 | -1% | N/A |
#3 | $15M | 267 | 5% | N/A |
#4 | $35M | 267 | 15% | N/A |
#5 | $72M | 267 | -3% | N/A |